Conquering CMV Viremia with CMV immunoglobulin, triumph in Renal Transplant Patients: A Case Series
Year: 2024
Type: article
Abstract: This case series offers the successful management of cytomegalovirus (CMV) viremia in patients who developed CMV infection post renal transplantation. The patients have been treated with three doses of CMV immunoglobulin and ganciclovir for 21 days. The CMV load in each affected person extensively reduced after treatment, indicating the effectiveness of this regimen in coping with CMV viremia in resource constrains setting
Source: Liaquat Medical Research Journal
Institution: Dow University of Health Sciences
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4405104664